Jun 08, 2021 / 06:10PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Welcome, everybody. My name is Matt Sykes. I'm the senior life science tools and diagnostics analyst at Goldman Sachs. Today, we have the pleasure of having Matt McGrew, the Executive Vice President and Chief Financial Officer; and Matt Gugino, the Head of Investor Relations from Danaher. I guess you have to be named Matt to be part of this panel. So I'm glad we all made it in.
Questions and Answers:
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research AnalystBut maybe Matt McGrew, I will start with you and just kind of maybe let you set the stage, talk a little bit about the recent quarter, some of the key drivers you see over the course of this year and kind of your views today.
Matthew R. McGrew - Danaher Corporation - CFO & Executive VP
Sure. So I mean I think maybe just kind of revisiting Q1 just to get people sort of grounded a little bit. We had a pretty good start to the year here in
Trustpilot
